APA

Squires K. E., Bekker L., Eron J. J., Cheng B., Rockstroh J. K., Marquez F., Kumar P., Thompson M., Campo R. E., Mounzer K., Strohmaier K. M., Lu C., Rodgers A., Jackson B. E., Wenning L. A., Robertson M., Nguyen B. T. & Sklar P. (20130830). Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study. : AIDS research and human retroviruses.

Chicago

Squires Kathleen E, Bekker Linda-Gail, Eron Joseph J, Cheng Benjamin, Rockstroh Juergen K, Marquez Farid, Kumar Princy, Thompson Melanie, Campo Rafael E, Mounzer Karam, Strohmaier Kim M, Lu Chengxing, Rodgers Anthony, Jackson Beth E, Wenning Larissa A, Robertson Michael, Nguyen Bach-Yen T and Sklar Peter. 20130830. Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study. : AIDS research and human retroviruses.

Harvard

Squires K. E., Bekker L., Eron J. J., Cheng B., Rockstroh J. K., Marquez F., Kumar P., Thompson M., Campo R. E., Mounzer K., Strohmaier K. M., Lu C., Rodgers A., Jackson B. E., Wenning L. A., Robertson M., Nguyen B. T. and Sklar P. (20130830). Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study. : AIDS research and human retroviruses.

MLA

Squires Kathleen E, Bekker Linda-Gail, Eron Joseph J, Cheng Benjamin, Rockstroh Juergen K, Marquez Farid, Kumar Princy, Thompson Melanie, Campo Rafael E, Mounzer Karam, Strohmaier Kim M, Lu Chengxing, Rodgers Anthony, Jackson Beth E, Wenning Larissa A, Robertson Michael, Nguyen Bach-Yen T and Sklar Peter. Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study. : AIDS research and human retroviruses. 20130830.